Evidence map›Paper›PMID 23255796›Full record

ArticleJournal of virology2013

Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections.

Kerry D Fitzgerald, Amanda J Chase, Andrea L Cathcart, Genevieve P Tran, Bert L Semler

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Oncogenic SRSF3 in health and diseases.International journal of biological sciences · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Microorganisms · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kerry D FitzgeraldDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, California, USA.
Amanda J Chase
Andrea L Cathcart
Genevieve P Tran
Bert L Semler
University of California, Irvine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Impact of host protein dynamics on picornavirus RNA 5’ noncoding region functionsR01AI026765 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEMLER, BERT L · 1988 to 2019
$5.9M
Virus-host interactions: a multi-scale training programT32AI007319 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEMLER, BERT L, SHI, YONGSHENG · 1988 to 2024
$2.4M
Functions of 5' NCRs of picornavirus and cellular mRNAsR56AI026765 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEMLER, BERT L · 2008 to 2008
$369k
NCI NIH HHS P30 CA062203NCI NIH HHS P30CA062203NIAID NIH HHS AI 07319NIAID NIH HHS AI 26765NIAID NIH HHS R01 AI026765NIAID NIH HHS R56 AI026765NIAID NIH HHS T32 AI007319
6 · The paper itself

Abstract

Infection of mammalian cells by picornaviruses results in the nucleocytoplasmic redistribution of certain host cell proteins. These viruses interfere with import-export pathways, allowing for the cytoplasmic accumulation of nuclear proteins that are then available to function in viral processes. We recently described the cytoplasmic relocalization of cellular splicing factor SRp20 during poliovirus infection. SRp20 is an important internal ribosome entry site (IRES) trans-acting factor (ITAF) for poliovirus IRES-mediated translation; however, it is not known whether other picornaviruses utilize SRp20 as an ITAF and direct its cytoplasmic relocalization. Also, the mechanism by which poliovirus directs the accumulation of SRp20 in the cytoplasm of the infected cell is currently unknown. Work described in this report demonstrated that infection by another picornavirus (coxsackievirus B3) causes SRp20 to relocalize from the nucleus to the cytoplasm of HeLa cells, similar to poliovirus infection; however, SRp20 is relocalized to a somewhat lesser extent in the cytoplasm of HeLa cells during infection by yet another picornavirus (human rhinovirus 16). We show that expression of poliovirus 2A proteinase is sufficient to cause the nucleocytoplasmic redistribution of SRp20. Following expression of poliovirus 2A proteinase in HeLa cells, we detect cleavage of specific nuclear pore proteins known to be cleaved during poliovirus infection. We also find that expression of human rhinovirus 16 2A proteinase alone can cause efficient cytoplasmic relocalization of SRp20, despite the lower levels of SRp20 relocalization observed during rhinovirus infection compared to poliovirus. Taken together, these results further define the mechanism of SRp20 cellular redistribution during picornavirus infections, and they provide additional insight into some of the differences observed between human rhinovirus and other enterovirus infections.

Indexed as

3C Viral ProteasesActive Transport, Cell NucleusCell Line, TumorCell NucleusCoxsackievirus InfectionsCysteine EndopeptidasesCytoplasmEnterovirus B, HumanHeLa CellsHumansMembrane GlycoproteinsNuclear Pore Complex ProteinsNuclear ProteinsPicornaviridae InfectionsPoliovirusRhinovirus3C Viral ProteasesCysteine EndopeptidasesMembrane GlycoproteinsNuclear Pore Complex Proteinsnuclear pore protein p62Nuclear ProteinsNUP153 protein, humanNup98 protein, humanpicornain 2A, PicornavirusRNA-Binding ProteinsSerine-Arginine Splicing FactorsSRSF3 protein, humanTrans-ActivatorsViral Proteins

Identifiers

PMID23255796
PMCPMC3571363
OpenAlexW2103235014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.